For the Inventor, By the Inventor

Enter assignee name

Orion-yhtyma Oy

USPTO Granted Patents = 112

CIPO Patents = 3

Trademarks = 5

Forward Citations = 1,834

Loading Chart...

Loading Chart...

188 inventors (with patents filed for the assignee):

Erkki J Honkanen (25 out of 28 patents)

Reijo J Backstrom (16 out of 19 patents)

Aino K Pippuri (16 out of 20 patents)

4. Erkki A Nissinen (12 out of 13 patents)

5. Pentti Pohto (11 out of 13 patents)

6. Inge-Britt Y Linden (11 out of 13 patents)

7. Jarmo J Pystynen (10 out of 20 patents)

8. Matti Rantanen (8 out of 10 patents)

9. Risto A Lammintausta (8 out of 23 patents)

10. Pekka J Kairisalo (7 out of 7 patents)

11. Heimo O Haikala (7 out of 16 patents)

12. Pentti T Nore (7 out of 11 patents)

13. Lauri V Kangas (7 out of 35 patents)

14. Arto J Karjalainen (6 out of 39 patents)

15. Anne M Luiro (6 out of 9 patents)

Core Competencies:

Competitive Exclusion Culture

Powder Inhaler

Solid Culture Medium

COMT Inhibitors

Aminoterminal Propeptides

Non-Competitive Immunoassay

Controlled Release Pharmaceutical

Bioceramic System

Triphenylethylenes

Dexmedetomidine

Topical Administration

Selective Aromatase Inhibitors

112 patents: Sort by Forward Citations

1. 6491910 - Ovo administration of a competitive exclusion culture (2002-12-10),

2. 6332461 - Powder inhaler (2001-12-25),

3. 6258586 - Solid culture medium for microorganisms, process for its preparation, and use (2001-07-10),

4. 6207706 - Use of COMT inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions (2001-03-27),

5. 6150412 - Catechol derivatives (2000-11-21),

6. 6149866 - Stopper having a cavity for reagents and an assay method using said (2000-11-21),

7. 6121303 - Pharmacologically active catechol derivatives (2000-09-19),

8. 6093803 - Method of producing aminoterminal propeptide of type 1 procollagen (2000-07-25),

9. 6090920 - Aminoterminal propeptides of typed 1 procollagen (2000-07-18),

10. 6046458 - Protective sheath for an image plate (2000-04-04),

11. 6037185 - Non-competitive immunoassay with blocking of unoccupied specific binding (2000-03-14),

12. 6028321 - Balancing means in a rotating reading device for an image plate and (2000-02-22),

13. 5962024 - Peroral composition for controlled release in the lower gastrointestinal (1999-10-05),

14. 5919482 - Gelatine capsule containing selegiline or derivative and paraffin as (1999-07-06),

15. 5919419 - Analyzer cuvette, method and diagnostic test kit for determination of (1999-07-06),

Orion Corporation is a Finnish pharmaceutical company that develops, manufactures, and markets pharmaceuticals and active pharmaceutical ingredients. The company focuses on neurological diseases, oncology treatments, and respiratory diseases. Orion-Yhtyma OY operates through two business segments: Pharmaceutical Products and Fermion. The Pharmaceutical Products segment includes the development, manufacturing, and marketing of pharmaceuticals and active pharmaceutical ingredients. The Fermion segment is responsible for the development and production of active pharmaceutical ingredients. Orion-Yhtyma OY was founded in 1917 and is headquartered in Espoo, Finland.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

112 Patents

#14 in Espoo

#39 in Finland

#6,840 in the World

Orion-yhtyma Oy

Forward Citations = 1,834

188 inventors:

Erkki J Honkanen (25 out of 28 patents)

Reijo J Backstrom (16 out of 19 patents)

Aino K Pippuri (16 out of 20 patents)

4. Erkki A Nissinen (12 out of 13 patents)

5. Pentti Pohto (11 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…